AIDSVAX Immunization Induces HIV-specific CD8+ T-cell Responses in High-risk, HIV-negative Volunteers Who Subsequently Acquire HIV Infection

Схожие документы

• Magnitude and breadth of a non-protective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine (AIDSVAX™ B/B)
  по: Gilbert, Peter, et al.
  Опубликовано: (2010)
• Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection
  по: Horton, Helen, et al.
  Опубликовано: (2006)
• Late Boosting of the RV144 Regimen with AIDSVAX B/E and ALVAC-HIV in HIV-Uninfected Thai Volunteers, a Randomised Controlled Trial
  по: Pitisuttithum, Punnee, et al.
  Опубликовано: (2020)
• Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
  по: Zolla-Pazner, Susan, et al.
  Опубликовано: (2013)
• Presence of Suppressor HIV-Specific CD8(+) T Cells Is Associated with Increased PD-1 Expression on Effector CD8(+) T Cells
  по: Elrefaei, Mohamed, et al.
  Опубликовано: (2008)